Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
W.BurroughsT
26 The ADA recommends monitoring HbA1c levels twice a year for patients at goal and four times a year for patients not at goal
Your provider may recommend temporarily reducing the dose, taking additional anti-nausea medication, or adjusting your titration schedule
Our clinicians will be with you every step of the way, ensuring that you achieve your weight loss goals safely and sustainably
More supply at a reasonable price is needed right now, not less
100% of patients in the REVEAL-1 Cohort maintained at least 5% of GLP-1-induced weight loss through one year: This 5% threshold is the responder definition used as the second co-primary endpoint in the REMAIN-1 Pivotal Cohort, which evaluates a responder rate among the Revita treated participants at one year to assess the durability of the Revita procedure for weight maintenance after GLP-1 discontinuation
